Healthcare Companies’ Insights From AI Helped a Pharma Company Gain the Edge Over Its Competitors.

Healthcare companies face a constant challenge: Skin conditions affect numerous people globally, and as such affect their appearance.

Due to this, healthcare companies must pick certain medications or brands to prescribe to their patients to overcome their struggles, but this poses an issue.

 The dermatology industry is a complex sector rife with competition. Navigating the industry can pose multiple struggles for pharma companies, as one such pharma company came to understand. To properly maneuver through this industry, the company contracted GrapheneAI to utilize its AI to pick up on chatter regarding the client brand and its competitors so that healthcare companies would be more inclined to prescribe their brand.

Through the knowledge of our domain experts and our complex, in-house AI, we understood that numerous drivers and factors were affecting the client brand’s perception among healthcare providers. We found that the emergence of a new biologic posed a problem for the client brand as it was considered an adequate alternative. Furthermore, it was also found that those intending to prescribe the new biologic were unhappy with the current support provided by the client.

Through our actionable insights and data, the client brand was able to learn what drivers and negative sentiments to act on, thus allowing them to gain the upper hand on their competitors by enacting the necessary changes.